Welcome to CMI's redesigned Research News.
Each issue will feature new developments in research, new client projects and methods, a highlight about a CMI team member, and
a spotlight on an upcoming industry event or conference.
We'd love to hear strategic questions you're considering
as you look ahead to the summer months. |
|
ISO 20252 Certification
School's In For Summer
While our children begin their summer vacations, we at CMI are learning and leading the charge for ISO 20252 guidelines for processes and performance for research organizations. CMI is proud to be one of four research companies to be beta testers of the new ISO guidelines established by CIRQ (CASRO Institute for Research Quality). CIRQ is the first U.S.-based certification body for ISO market, opinion, and social research process standards. Process standards outlined in ISO 20252 are designed to produce transparent, consistent, well-documented and error-free methods of conducting and managing research projects. Our first phase of training to become ISO certified begins in June.
Click for more information
|
|
Digging Deeper into
Survey Responses
In March, CMI conducted a quantitative survey on behalf of Pfizer in order to understand physician attitudes and usage of one of their prescription medications. Through this research, we identified a decision-making process among a cohort of physicians that the Pfizer team wanted to understand in much greater detail. The Pfizer/CMI team developed a fast turnaround process for re-contacting the specific physicians who were part of this cohort and offering an easy website to schedule a phone in-depth interview (IDI) with trained CMI moderators. The 15-minute IDIs allowed the physicians to easily accommodate the interviews into their busy appointment schedules.
In very little time and with limited additional expense, Pfizer was quickly able to dig deeper to reveal detailed information about the decision-making behavior of these key physicians. The doctors provided an abundance of important insights that are being used by this global pharmaceutical company to revamp the communications and approach that sales detailers will use with similar doctors going forward.
|
